Request Trial
shutterstock_1214634313_piotr_swat
Piotr Swat / Shutterstock.com
28 January 2020PharmaEdward Pearcey

AbbVie’s pending Allergan takeover moves closer after drug divestments

Biopharmaceutical company  AbbVie’s pending purchase of pharmaceutical company  Allergan has moved a step closer, following the latter’s agreement to divest treatments brazikumab (IL-23 inhibitor) and Zenpep (pancrelipase), in a development meant to satisfy antitrust regulations in the US.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Pharma
USPTO director steps into Sun Pharma’s PTAB-ITC clash
31 July 2026   A director review has overturned a PTAB ruling, questioning why it diverged from an ITC decision based on the same patent claims, prior art and evidence.
Pharma
Pharmascience v Janssen: Canada court updates methods of medical treatment protection
23 July 2026   Canada has firmly slammed the door on patenting methods of medical treatment—but the battle over what counts as a "medical method" is only just beginning. Scott MacKendrick of ROBIC examines a landmark decision that leaves the door ajar for future litigation over complex drug-dosing regimens.
Pharma
Exelixis opens two-front patent dispute over Cabometyx copies
9 July 2026   Separate lawsuits target Indian and Taiwanese pharma companies as Exelixis seeks to keep rival cabozantinib products off the US market until key patents expire.


Editor's picks

Where Big Pharma is betting big in the M&A boom
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026

Editor's picks

Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026
Regulation & Industry
Why is 2026 already a record year for M&A activity?
17 July 2026
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026
Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026
Biotech
Pfizer’s US Paxlovid patent fight turns on a single error
25 June 2026
Regulation & Industry
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
25 June 2026

More features

Arnold & Porter adds firepower to ITC practice with new partner hire
USPTO director steps into Sun Pharma’s PTAB-ITC clash
USPTO appoints new acting commissioner for patents
European court strikes down hearing aid sensor patent
Where Big Pharma is betting big in the M&A boom
Fish & Richardson adds AI and medical device specialist
Boston Scientific overturns $42m patent verdict on appeal
Buying the brains: Why is Big Pharma shopping for innovation?